Neon Therapeutics, Inc. SEC Filings

Filed On	Filing
18 May 2020	15-12B
13 May 2020	EFFECT
06 May 2020	Form 4: Zausner Meryl, Director Disposed of 72,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Tepper Robert I, Director Returned 9,741,636 shares to the issuer · Disposed of 32,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Sherwin Stephen A, Director Returned 45,000 shares to the issuer · Disposed of 37,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Pfeffer Cary, Director Returned 0 shares to the issuer · Disposed of 32,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Lander Eric S, Director Returned 134,000 shares to the issuer · Disposed of 32,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Kamen Robert, Director Disposed of 32,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Bazemore Robert B, Director Disposed of 46,500 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Gaynor Richard, President of R&D Returned 210,410 shares to the issuer · Disposed of 318,378 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Siegel Jolie, VP, General Counsel Returned 161,821 shares to the issuer · Disposed of 160,000 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: Al-Wakeel Yasir B., Chief Financial Officer Returned 196,965 shares to the issuer · Disposed of 353,790 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	Form 4: O'Dowd Hugh, Director Returned 776,085 shares to the issuer · Disposed of 762,694 Stock Option (Right to Buy) (Disposition to Issuer)
06 May 2020	S-8 POS
06 May 2020	S-8 POS
06 May 2020	S-8 POS
06 May 2020	POS AM
06 May 2020	25-NSE
06 May 2020	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +5 more
05 May 2020	8-K: Submission of Matters to a Vote of Security Holders

Comments